Medcool's RapidCool technology:
This article was originally published in Clinica
Executive Summary
Medcool has received US FDA 510(k) clearance to market its noninvasive RapidCool system for reducing head and body temperature where clinically indicated - eg in hyperthermic patients. The device uses a patented disposable helmet that directs agitated cold water to the scalp, plus standard body and neck pads to rapidly cool the head and body. It reduces temperature to a set point in the range of 32-37 degrees C, and does not interfere with other hospital procedures such as cardiac catheterisation. A growing body of research indicates that mild hypothermia, in the range of 32-34 degrees C, could have a protective effect, reducing damage from cardiac arrest, stroke, brain injury and other traumatic events, said the Wellesley, Massachusetts firm.